BRPI0514524A - nanopartìculas e processo para sua fabricação - Google Patents

nanopartìculas e processo para sua fabricação

Info

Publication number
BRPI0514524A
BRPI0514524A BRPI0514524-4A BRPI0514524A BRPI0514524A BR PI0514524 A BRPI0514524 A BR PI0514524A BR PI0514524 A BRPI0514524 A BR PI0514524A BR PI0514524 A BRPI0514524 A BR PI0514524A
Authority
BR
Brazil
Prior art keywords
nanoparticles
gelatin
maximum
manufacture
production
Prior art date
Application number
BRPI0514524-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Michael Ahlers
Conrad Coester
Klaus Zwiorek
Jan Zillies
Original Assignee
Gelita Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelita Ag filed Critical Gelita Ag
Publication of BRPI0514524A publication Critical patent/BRPI0514524A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Jellies, Jams, And Syrups (AREA)
BRPI0514524-4A 2004-08-20 2005-08-18 nanopartìculas e processo para sua fabricação BRPI0514524A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004041340A DE102004041340A1 (de) 2004-08-20 2004-08-20 Nanopartikel und Verfahren zu deren Herstellung
PCT/EP2005/008954 WO2006021367A1 (de) 2004-08-20 2005-08-18 Nanopartikel und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
BRPI0514524A true BRPI0514524A (pt) 2008-06-10

Family

ID=35276582

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0514524-4A BRPI0514524A (pt) 2004-08-20 2005-08-18 nanopartìculas e processo para sua fabricação

Country Status (14)

Country Link
US (1) US20080003292A1 (enExample)
EP (1) EP1793810A1 (enExample)
JP (1) JP2008510688A (enExample)
KR (1) KR20070046850A (enExample)
CN (1) CN1988892A (enExample)
AU (1) AU2005276675A1 (enExample)
BR (1) BRPI0514524A (enExample)
CA (1) CA2575407A1 (enExample)
DE (1) DE102004041340A1 (enExample)
IL (1) IL180954A0 (enExample)
MX (1) MX2007001996A (enExample)
NO (1) NO20071458L (enExample)
NZ (1) NZ551326A (enExample)
WO (1) WO2006021367A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006325225B2 (en) 2005-12-14 2013-07-04 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
WO2007072982A1 (en) * 2005-12-20 2007-06-28 Fujifilm Corporation Protein nanoparticles and the use of the same
JP2007224012A (ja) * 2006-01-30 2007-09-06 Fujifilm Corp 酵素架橋したタンパク質ナノ粒子
SI2032592T1 (sl) 2006-06-12 2013-10-30 Cytos Biotechnology Ag Postopki za pakiranje oligonukleotidov v virusu-podobne delce RNA bakteriofagov
JP2008001764A (ja) * 2006-06-21 2008-01-10 Gunma Univ タンパク質からなる粒子状成形体の製造方法及び、該方法により得られたタンパク質からなる粒子状成形体
JP5275561B2 (ja) * 2006-10-30 2013-08-28 富士フイルム株式会社 水分散可能なナノ粒子
DE602007002784D1 (de) * 2007-03-16 2009-11-26 Univ Nat Chi Nan Bioabbaubares Material mit Nanoporen und elektrischer Leitfähigkeit sowie Herstellungsverfahren dafür
JP2008260705A (ja) * 2007-04-11 2008-10-30 Fujifilm Corp 注射用組成物
JP2008297241A (ja) * 2007-05-31 2008-12-11 Fujifilm Corp ニキビ用皮膚外用剤
DE102007041625A1 (de) * 2007-09-03 2009-03-05 Sinn, Hannsjörg, Dr. Neue Gelatine-Wirkstoff-Konjugate
US9724367B2 (en) * 2010-11-10 2017-08-08 Regenmed (Cayman) Ltd. Injectable formulations for organ augmentation
EP2540287A1 (en) 2011-07-01 2013-01-02 FutureChemistry Continuous flow production of gelatin nanoparticles
DE102011052396A1 (de) * 2011-08-04 2013-02-07 Gelita Ag Verfahren zur Herstellung einer stabilen Dispersion von Nanopartikeln, hergestellte Dispersion und deren Verwendung
JP6851987B2 (ja) * 2015-12-25 2021-03-31 コニカミノルタ株式会社 ゼラチン粒子、ゼラチン粒子の製造方法、ゼラチン粒子内包細胞、およびゼラチン粒子内包細胞の製造方法
US11207258B2 (en) 2016-01-25 2021-12-28 Suntory Holdings Limited Capsule containing functional substance and method for manufacturing said capsule
CN107376008B (zh) 2017-07-21 2019-10-22 深圳华诺生物科技有限公司 一种无机纳米颗粒-明胶核壳结构复合材料颗粒的制备方法
WO2021132741A1 (ko) * 2019-12-23 2021-07-01 주식회사 피엘마이크로메드 색전 시술 입자 및 이의 제조방법
WO2021146240A1 (en) 2020-01-13 2021-07-22 Cargill, Incorporated Turkey collagen hydrolysates and methods of making
EP3954399B1 (en) * 2020-04-09 2023-11-15 Plmicromed Co., Ltd. Microbeads for embolization and composition for treating proliferative diseases
KR102386631B1 (ko) * 2020-04-09 2022-04-15 주식회사 피엘마이크로메드 색전 시술용 마이크로 비드 및 증식성 질환 치료용 조성물
KR102645182B1 (ko) * 2021-08-23 2024-03-07 전남대학교산학협력단 젤라틴 가교입자의 제조 방법
KR102861315B1 (ko) * 2022-07-26 2025-09-18 전남대학교산학협력단 작물 생장 촉진용 조성물
US20240049705A1 (en) * 2022-07-26 2024-02-15 Industry Foundation Of Chonnam National University Composition for enhancing growth of plants

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
AU671965B2 (en) * 1991-12-05 1996-09-19 Alfatec-Pharma Gmbh Pharmaceutically Applicable Nanosol and Process for Preparing The Same
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140195C2 (de) * 1991-12-05 1994-10-27 Alfatec Pharma Gmbh Pharmazeutisch applizierbares Nanosol und Verfahren zu seiner Herstellung
DE19838189A1 (de) * 1998-08-24 2000-03-02 Basf Ag Stabile pulverförmige Vitamin- und Carotinoid-Zubereitungen und Verfahren zu deren Herstellung
DE60024791T2 (de) * 1999-04-08 2006-07-06 The Johns Hopkins University Antigen-spezifische induktion der peripheren immuntoleranz
US7713551B2 (en) * 2002-09-11 2010-05-11 Elan Pharma International Ltd. Gel stabilized nanoparticulate active agent compositions
CA2435632A1 (en) * 2003-07-21 2005-01-21 Warren Hugh Finlay Formulation of powder containing nanoparticles for aerosol delivery to the lung

Also Published As

Publication number Publication date
KR20070046850A (ko) 2007-05-03
EP1793810A1 (de) 2007-06-13
IL180954A0 (en) 2007-07-04
NO20071458L (no) 2007-03-19
US20080003292A1 (en) 2008-01-03
NZ551326A (en) 2010-04-30
CA2575407A1 (en) 2006-03-02
AU2005276675A1 (en) 2006-03-02
CN1988892A (zh) 2007-06-27
DE102004041340A1 (de) 2006-02-23
WO2006021367A1 (de) 2006-03-02
MX2007001996A (es) 2007-05-10
JP2008510688A (ja) 2008-04-10

Similar Documents

Publication Publication Date Title
Ng et al. Monitoring the degradation of collagen hydrogels by collagenase clostridium histolyticum
Elangwe et al. Pullulan-based hydrogels in wound healing and skin tissue engineering applications: a review
Pedro et al. The importance of antioxidant biomaterials in human health and technological innovation: a review
Conte et al. Hyaluronic acid hydrogel containing resveratrol-loaded chitosan nanoparticles as an adjuvant in atopic dermatitis treatment
Antoszewska et al. Wide use of hyaluronic acid in the process of wound healing—A rapid review
Cadinoiu et al. Silver nanoparticles biocomposite films with antimicrobial activity: In vitro and in vivo tests
Valachova et al. Impact of ergothioneine, hercynine, and histidine on oxidative degradation of hyaluronan and wound healing
Derkach et al. Rheological properties of fish gelatin modified with sodium alginate
Pontecorvi et al. Assessing the impact of polyethylene nano/microplastic exposure on human vaginal keratinocytes
Iacob et al. Preparation, characterization and wound healing effects of new membranes based on chitosan, hyaluronic acid and arginine derivatives
Makvandi et al. Natural formulations provide antioxidant complement to hyaluronic acid-based topical applications used in wound healing
Salesa et al. Carbon nanofibers versus silver nanoparticles: time-dependent cytotoxicity, proliferation, and gene expression
MX2007001996A (es) Nanoparticulas y metodo para su produccion.
Lewandowska et al. Rheological and film-forming properties of chitosan composites
Martins et al. In vivo skin hydrating efficacy of fish collagen from greenland halibut as a high-value active ingredient for cosmetic applications
Abdalrazeq et al. Glycerol-plasticized films obtained from whey proteins denatured at alkaline pH
BRPI0311700B8 (pt) processo para a produção de uma preparação em forma de película e preparação em forma de película
Araújo et al. Chitin-glucan complex hydrogels: optimization of gel formation and demonstration of drug loading and release ability
BR112015028278A2 (pt) processo para a preparação de eritrócitos carregados com uma ou mais substâncias de interesse farmacêutico e eritrócitos assim obtidos
Espinoza et al. Comparative study of donepezil-loaded formulations for the treatment of Alzheimer’s disease by nasal administration
Gehrcke et al. Novel pullulan/gellan gum bilayer film as a vehicle for silibinin-loaded nanocapsules in the topical treatment of atopic dermatitis
Gehwolf et al. Global responses of Il-1β-primed 3D tendon constructs to treatment with pulsed electromagnetic fields
Suhail et al. In vitro evaluation of smart and pH-sensitive chondroitin sulfate/sodium polystyrene sulfonate hydrogels for controlled drug delivery
Cheng et al. Protective effect of ectoin on UVA/H2O2-induced oxidative damage in human skin fibroblast cells
Raza et al. Synthesis and characterization of Hyaluronic Acid (HA) modified polymeric composite for effective treatment of wound healing by transdermal drug delivery system (TDDS)

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: CONFORME ARTIGO 10O DA RESOLUCAO 124/06, CABE SER ARQUIVADO REFERENTE AO NAO RECOLHIMENTO DA 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2138 DE 27/12/2011.

B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A61K 9/48; A61K 9/14; A61K 9/50; A61K 9/51; A61K 47/48.

Ipc: A61K 9/51 (2006.01), B82Y 5/00 (2011.01)

Ipc: A61K 9/51 (2006.01), B82Y 5/00 (2011.01)